Schedule 13G ownership disclosure
Corcept Therapeutics Inc
Security class unavailable · CUSIP: 218352102
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-016832
- Form type
- SC 13G
- Filer
- BELANOFF JOSEPH K
- CIK
- CIK 1286199
- Filed
- Jan 24, 2017
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership